Danske Bank’s Oncternal Therapeutics, Inc. Common Stock ONCT Stock Holding History

Danske Bank’s Portfolio ONCT Stock Details ONCT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-1	Closed	-$1	–	1698
2024 Q3	$1	Buy	+1	New	+$5	﹤0.01%	1604

Other funds holding ONCT

SPIA

Steward Partners Investment Advisory New York $19.6B AUM 29.84% 1-Year Est. Return

NRG

Nemes Rush Group Novi, Michigan $1.21B AUM 33.22% 1-Year Est. Return

Danske Bank's ONCT Position: Q4 2024 in Review

Danske Bank sold out of Oncternal Therapeutics, Inc. Common Stock (ONCT) in Q4 2024, closing a stake of 1 share — an estimated $1 sold.

Danske Bank first reported a position in ONCT in Q3 2024 and held it in 1 quarter. The position peaked at $1 in Q3 2024. 4 funds tracked by Wall St. Rank hold ONCT as of Q4 2024.

Danske Bank reported no remaining Oncternal Therapeutics, Inc. Common Stock position as of Q4 2024 after selling out during the quarter.
Danske Bank sold 1 Oncternal Therapeutics, Inc. Common Stock share in Q4 2024, an estimated $1.
Danske Bank first reported a position in Oncternal Therapeutics, Inc. Common Stock in Q3 2024 and held it in 1 quarter.
Danske Bank's Oncternal Therapeutics, Inc. Common Stock position peaked at $1 in Q3 2024.
4 funds tracked by Wall St. Rank held Oncternal Therapeutics, Inc. Common Stock as of Q4 2024.

Based on Danske Bank's 13F filing for Q4 2024, filed 18 Mar 2026.